Aldeyra Therapeutics Inc
SWB:137
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aldeyra Therapeutics Inc
SWB:137
|
US |
|
I
|
Iberpapel Gestion SA
MAD:IBG
|
ES |
|
I
|
Indus Holding AG
DUS:INH
|
DE |
|
B
|
Basf Se
XHAN:BAS
|
DE |
|
A
|
American Water Works Co Inc
XHAN:AWC
|
US |
|
Towa Corp
F:TWA
|
JP |
|
L
|
L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA
XHAN:AIL
|
FR |
|
John B Sanfilippo & Son Inc
F:JO1
|
US |
|
F
|
Forbo Holding AG
XBER:FOZN
|
CH |
|
S
|
Sky ICT PCL
SET:SKY
|
TH |
|
F
|
Federal Agricultural Mortgage Corp
F:A35
|
US |
|
D
|
Digital Workforce Services Oyj
F:DQ4
|
FI |
|
S
|
Suntory Beverage & Food Ltd
F:7SN
|
JP |
|
S
|
Surteco Group SE
DUS:SUR
|
DE |
|
V
|
Vinci SA
XHAN:SQU
|
FR |
|
Figeac Aero SARL
LSE:0RFM
|
FR |
|
Vontier Corp
F:47O
|
US |
|
SIIX Corp
OTC:SIIXF
|
JP |
|
J
|
JPMorgan Chase & Co
XHAN:CMC
|
US |
|
Prosafe SE
OTC:PRSEF
|
NO |
Bankruptcy Probability
Aldeyra Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Aldeyra Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Aldeyra Therapeutics Inc
NASDAQ:ALDX
|
96.5m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
454.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
209.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
122.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Aldeyra Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Aldeyra Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
